Article de Périodique
Synthetic cannabinoid induced psychosis in a previously nonpsychotic patient (2012)
Auteur(s) :
PEGLOW, S. ;
BUCHNER, J. ;
BRISCOE, G.
Année
2012
Page(s) :
287-288
Sous-type de document :
Etude de cas / Case report
Langue(s) :
Anglais
Refs biblio. :
9
Domaine :
Drogues illicites / Illicit drugs
Discipline :
PSY (Psychopathologie / Psychopathology)
Thésaurus mots-clés
TROUBLE BIPOLAIRE
;
ETUDE DE CAS
;
CANNABINOIDES
;
DROGUES DE SYNTHESE
;
PSYCHOSE
Thésaurus géographique
ETATS-UNIS
Résumé :
Synthetic cannabinoids are relatively new substances that have become rapidly popular among young adults. Despite their legal status in most states, they are virtually unregulated and unstudied. Nevertheless, recent case studies have brought new attention to their potentially harmful side effects, such as psychosis, agitation, and withdrawal. This case report examines the acute psychosis displayed by a psychiatric patient after smoking "Spice," a substance comprised of various synthetic cannabinoids, on three separate occasions. Furthermore, in comparing this patient's lack of psychotic symptoms after tetrahydrocannabinol (THC) use, to the episodes of psychosis experienced after "Spice" consumption this case study explores the possibility that synthetic cannabinoids are more potent than their organic counterpart. This is the first case report of synthetic cannabinoid-induced psychosis in a previously nonpsychotic patient. [Extract]
Affiliation :
Department of Psychiatry and Behavioral Medicine, Eastern Virginia Medical School, Norfolk, Virginia Department of Psychiatry, Hampton Veterans Affairs Medical Center, Hampton, Virginia, USA
Historique